Procurement Summary
Country: Brazil
Summary: Registration of Prices for the Acquisition of Failed Items Referring to Processes Nº 99003/2025 and 99004/2025 Basic Pharmacy Medicines, Assistance Use, Mental Health Program, Controlled Use, ...
Deadline: 15 Apr 2026
Posting Date: 01 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 138830145
Document Ref. No.: 99016/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Record of prices for the acquisition of failed items referring to processes nº 99003/2025 and 99004/2025 basic pharmacy medicines, assistance use, mental health program, controlled use, veterinary use and demand judicial; Processes nº 99008/2025 and 99009/2025 basic technical and hospital materials; and Processes No. 99010/2025 and 99011/2025 medicines, dental chemicals, instrumental materials and consumables for dental use. UASG Code: 980425 Notice from: 01/04/2026 from 08:00 to 12:00 and from 13:00 to 17:00 Proposal Delivery: from 04/01/2026 at 08:00 ACICLOVIR, DOSAGE 400 MG Quantity: 37132 ASCORBIC ACID, CONCENTRATION 500 MG, PHARMACEUTICAL FORM RELEASE PROLONGED Quantity: 1256 MEDICINAL EXTRACT, ACTIVE INGREDIENT HORSE CHESTNUT (AESCULUS HIPPOCASTANUM L.), CONCENTRATION 100 MG Quantity: 690 FORMOTEROL FUMARATE, COMPOSITION ASSOCIATED WITH BUDESONIDE, CONCENTRATION 12 MCG + 400MCG/DOSE, PHARMACEUTICAL FORM INHALER POWDER CAPSULE, ADDITIONAL CHARACTERISTICS WITH INHALER BOTTLE Quantity: 207 APIXABANA, CONCENTRATION 5 MG Quantity: 5520 KETOPROFEN, CONCENTRATION 100 MG Quantity: 20182 KETOPROFEN, CONCENTRATION 100 MG, PHARMACEUTICAL FORM LYOPHILE POWDER FOR INJECTABLE Quantity: 64653 KETOPROFEN, DOSAGE 20 MG/ML, CONCENTRATION ORAL SOLUTION/DROPS Quantity: 10005 CLARITHROMYCIN, DOSAGE 500 MG, INJECTABLE PRESENTATION Quantity: 1932 CIPROFLOXACIN HYDROCHLORIDE, COMPOSITION ASSOCIATED WITH HYDROCORTISONE, CONCENTRATION2 MG + 10 MG/ML, PHARMACEUTICAL FORM ENT SUSPENSION Quantity: 14490 CIPROFLOXACIN HYDROCHLORIDE, COMPOSITION ASSOCIATED WITH HYDROCORTISONE, CONCENTRATION 2 MG + 10 MG/ML, PHARMACEUTICAL FORM ENT SUSPENSION Quantity: 10764 PROXIMETHACAINE HYCLORIDATE, DOSAGE 0.5%, INDICATION FOR EYE DROPS Quantity: 28 CLOTRIMAZOLE, COMPOSITION ASSOCIATED WITH GENTAMICIN SULFA...
Documents
Tender Notice